Health
OXGENE launches a scalable, plasmid-free manufacturing system for AAV – News-Medical.net
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV.
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV. OXGENE’s new TESSA™ technology addresses industry-wide challenges associated with robust and reproducible AAV manufacture at scale. These include high cost of goods, and low packaging efficiency. TESSA aims to deliver a paradigm shift in scalable AAV manufacture.
Adeno-associated virus, or AAV, is a popular choic…
-
Noosa News24 hours agoWhat has the premier changed about the Queensland government logo? Take the Brisbane Times Quiz
-
General14 hours agoJim Chalmers will have to juggle competing demands to secure tax reform
-
Noosa News13 hours agoFather found stabbed dead upstairs at teenagers’ Brisbane house party
-
Noosa News24 hours agoNew 2032 Brisbane Olympic Games funding deal likely within weeks, federal and Queensland governments say